Cargando…

非小细胞肺癌13组、14组淋巴结转移规律探讨

BACKGROUND AND OBJECTIVE: Lymph node metastasis is one of the important factors affecting the tumor-node-matastasis (TNM) staging of lung cancer. In patients with surgery, 13 groups and 14 groups of lymph nodes ignored because of the deep hidden in the lung. In this paper, the positive detection rat...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999675/
https://www.ncbi.nlm.nih.gov/pubmed/28442013
http://dx.doi.org/10.3779/j.issn.1009-3419.2017.04.04
_version_ 1783331475093979136
collection PubMed
description BACKGROUND AND OBJECTIVE: Lymph node metastasis is one of the important factors affecting the tumor-node-matastasis (TNM) staging of lung cancer. In patients with surgery, 13 groups and 14 groups of lymph nodes ignored because of the deep hidden in the lung. In this paper, the positive detection rate of 13 groups and the 14 groups of lymph nodes in non-small cell lung cancer (NSCLC) and their effects on pathological stage were studied. METHODS: 100 cases of NSCLC were collected from the Affiliated Hospital of Inner Mongolia Medical University as the research object, cut out the intrathoracic 2-12 group, 13, 14 lymph node metastasis rate for pathological examination, relationship factors of statistical analysis of the size of primary tumor, location, pathological type and lymph node. RESULTS: 100 cases of patients with intrathoracic lymph node metastasis rate was 47.0%, with the 10-12 groups lymph node, N2 lymph nodes, 13, 14 groups lymph node positive rate had significant differences (P < 0.05); T stage 13, 14 groups of lymph node detection rate has statistically significant difference (P < 0.05); peripheral and central NSCLC stage N1 undetected rate no statistical difference (P>0.05); various pathological types of tumors between N(1) missed rate had no significant difference (P>0.05). In addition, 12 patients were found to have non-tumor-derived lobe lymph node metastasis. CONCLUSION: It is necessary to detect the metastatic lymph nodes of 13, 14 group and non-tumor-derived lobe in NSCLC. It is helpful to obtain accurate TNM staging and to guide postoperative treatment.
format Online
Article
Text
id pubmed-5999675
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-59996752018-07-06 非小细胞肺癌13组、14组淋巴结转移规律探讨 Zhongguo Fei Ai Za Zhi 临床研究 BACKGROUND AND OBJECTIVE: Lymph node metastasis is one of the important factors affecting the tumor-node-matastasis (TNM) staging of lung cancer. In patients with surgery, 13 groups and 14 groups of lymph nodes ignored because of the deep hidden in the lung. In this paper, the positive detection rate of 13 groups and the 14 groups of lymph nodes in non-small cell lung cancer (NSCLC) and their effects on pathological stage were studied. METHODS: 100 cases of NSCLC were collected from the Affiliated Hospital of Inner Mongolia Medical University as the research object, cut out the intrathoracic 2-12 group, 13, 14 lymph node metastasis rate for pathological examination, relationship factors of statistical analysis of the size of primary tumor, location, pathological type and lymph node. RESULTS: 100 cases of patients with intrathoracic lymph node metastasis rate was 47.0%, with the 10-12 groups lymph node, N2 lymph nodes, 13, 14 groups lymph node positive rate had significant differences (P < 0.05); T stage 13, 14 groups of lymph node detection rate has statistically significant difference (P < 0.05); peripheral and central NSCLC stage N1 undetected rate no statistical difference (P>0.05); various pathological types of tumors between N(1) missed rate had no significant difference (P>0.05). In addition, 12 patients were found to have non-tumor-derived lobe lymph node metastasis. CONCLUSION: It is necessary to detect the metastatic lymph nodes of 13, 14 group and non-tumor-derived lobe in NSCLC. It is helpful to obtain accurate TNM staging and to guide postoperative treatment. 中国肺癌杂志编辑部 2017-04-20 /pmc/articles/PMC5999675/ /pubmed/28442013 http://dx.doi.org/10.3779/j.issn.1009-3419.2017.04.04 Text en 版权所有©《中国肺癌杂志》编辑部2017 https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/
spellingShingle 临床研究
非小细胞肺癌13组、14组淋巴结转移规律探讨
title 非小细胞肺癌13组、14组淋巴结转移规律探讨
title_full 非小细胞肺癌13组、14组淋巴结转移规律探讨
title_fullStr 非小细胞肺癌13组、14组淋巴结转移规律探讨
title_full_unstemmed 非小细胞肺癌13组、14组淋巴结转移规律探讨
title_short 非小细胞肺癌13组、14组淋巴结转移规律探讨
title_sort 非小细胞肺癌13组、14组淋巴结转移规律探讨
topic 临床研究
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999675/
https://www.ncbi.nlm.nih.gov/pubmed/28442013
http://dx.doi.org/10.3779/j.issn.1009-3419.2017.04.04
work_keys_str_mv AT fēixiǎoxìbāofèiái13zǔ14zǔlínbājiézhuǎnyíguīlǜtàntǎo
AT fēixiǎoxìbāofèiái13zǔ14zǔlínbājiézhuǎnyíguīlǜtàntǎo
AT fēixiǎoxìbāofèiái13zǔ14zǔlínbājiézhuǎnyíguīlǜtàntǎo
AT fēixiǎoxìbāofèiái13zǔ14zǔlínbājiézhuǎnyíguīlǜtàntǎo
AT fēixiǎoxìbāofèiái13zǔ14zǔlínbājiézhuǎnyíguīlǜtàntǎo